The WHI scientific community encourages ancillary study proposals from within and beyond the WHI community.
It is recommended that proposals be submitted to ASC at least 3 months before the funding agency's submission deadline since the ASC may have questions or comments and more than one round of reviews may be required. Consortium studies may need additional time since it requires review/initial screening by the SRWG prior to submission to the ASC.
First business day of the month
Third Tuesday of the month
Approximately one week after review
WHI Ancillary Study (AS): An investigation that involves generation of new data not already in the WHI database. Examples include:
Specimen assay results
Abstraction of records previously collected by WHI but not yet coded (e.g., four-day food records, medical records)
Collection of new survey data or clinical data
Initial review of proposed ancillary studies is conducted by the WHI Ancillary Studies Committee (ASC).Paper Proposals: Projects using or constructing new variables from existing WHI data.
Consortium Proposals: Multi-study or multi-cohort research projects.
Before submitting an ancillary study, please read the following documents:
Application Procedures Guide
Submit a WHI AS Application:
Application form (right-click and select "Save as" to save form to your PC)
DSMB Participant Burden Summary Form (right-click and select "Save as" to save form to your PC) for projects involving participants
AS Modification Request form. Any proposed changes to the design of an ASC approved AS, including changes in sample size, biomarkers, or use of specimens (including use of residual specimen), must be approved by the ASC. Please email form to email@example.com.
Prepare Budget, after ASC approval:
Once ASC-approved, contact the CCC to develop a subaward budget, if needed. Refer to the CCC AS Coordinator contact listed on your ASC approval letter.
CCC Intake Form
Sample Budget Info:
Sample Budget Detail,
Sample Work Scope
Current and Completed Studies: lists of approved and funded ancillary studies. Ancillary study proposals that overlap with previous and ongoing WHI research are not likely to be approved.
WHI Data: information on data already collected, including specimen results that are available. Access to detailed data may require the assistance of the sponsoring PI or CCC, particularly for studies where additional coding is required (e.g., medications).
Biospecimen Available for Use: information about blood and urine collection time points, volume of sample available to AS, descriptions of specimen collection, processing, storage, and quality control, and the timelines for obtaining biospecimens and data
Query Builder: a tool designed to create queries based on study components, demographics, outcomes, specimen availability, test results and more.
dbGaP Quick Information Sheet
WHI Help Desk (firstname.lastname@example.org): for assistance when not finding information through the website